Newsletter | March 18, 2024

03.18.24 -- Osmotic Controlled Release Oral Drug Delivery: A Closer Look


Webinar: Optimizing Pediatric Product Development For Commercialization Success

Join us on April 10th to discover the secrets of streamlining your pediatric product development journey. We’ll cover regulatory requirements and challenges in formulation development associated with the diversity of the population. We’ll also explore various dosing solutions and strategies that can efficiently address these formulation challenges. Click here to learn more.


Osmotic Controlled Release Oral Drug Delivery: A Closer Look

Osmotic controlled release drug delivery is not often spoken about, but it is a useful oral drug formulation technology. This article shares the mechanisms of the elements of oral dosage, including the semi-permeable membrane, pore-forming agents, and more, as well as the advantages and applications of this type of drug delivery.


Is It Ever Too Soon To Start Your Performance Testing Assessment?

Developing a safe and effective injectable combination product involves performing risk assessments, establishing a set of critical quality attributes (CQAs), and performing design verification testing.

Ensure Speed And Success With Your Drug Delivery Project

Hear from experienced professionals in the drug delivery space on how to ensure success and speed-to-market by establishing a firm foundation when working with a CMO.

Utilizing Nanoparticle Technologies For A More Sustainable Value Chain

The pharma industry is identifying ways to make processes more sustainable. Learn how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.

Leverage Solvent-Free Amorphous Solid Dispersion Technology

Explore how a solvent-free alternative for producing amorphous solid dispersions (ASDs) not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.

The Path To Self-Administration: Moving From PFS To Auto-Injector

Review advice to pharma companies on three key areas of auto-injector device development: patient-centered design, container and device considerations, and manufacturing partner selection.

High-Throughput Platform Propels Gene Editing Therapy Research

Explore the potential of polymeric nanoparticles (PNPs) as an alternative to viral vectors. PNPs offer design flexibility, enabling larger payloads, targeted release, and minimized side effects.


Designed For Inhalation: Pulmonary And Nasal Delivery

Delivering Integrated End-To-End Services For Oral Dosage Forms

Inhaled Product Development